| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTD | 2,250,000 | 120,398,000 | 7.05% | ||
| 2 | MYLAN N V | 1,850,000 | 85,748,000 | 5.02% | ||
| 3 | MEDICINES CO | 2,500,000 | 79,425,000 | 4.65% | ||
| 4 | BROOKDALE SR LIVING INC | 5,000,000 | 79,400,000 | 4.65% | ||
| 5 | NUVASIVE INC COM | 1,500,000 | 72,975,000 | 4.27% | ||
| 6 | ST JUDE | 1,250,000 | 68,750,000 | 4.03% | ||
| 7 | SELECT MED HLDGS CORP COM | 5,575,000 | 65,841,000 | 3.86% | ||
| 8 | LIVANOVA PLC | 1,200,000 | 64,776,000 | 3.79% | ||
| 9 | ORTHOFIX INTERNATIONAL NV | 1,500,000 | 62,280,000 | 3.65% | ||
| 10 | NEKTAR THERAPEUTICS COM | 4,500,000 | 61,875,000 | 3.62% | ||
| 11 | GENOMIC HEALTH INC COM | 2,458,100 | 60,887,000 | 3.57% | ||
| 12 | LDR HLDG CORP COM | 2,250,000 | 57,353,000 | 3.36% | ||
| 13 | TEVA PHARMACEUTICAL INDS LTD | 1,000,000 | 53,510,000 | 3.13% | Call | |
| 14 | VALEANT PHARMACEUTICALS INTL | 2,000,000 | 52,600,000 | 3.08% | ||
| 15 | ABBVIE INC | 900,000 | 51,408,000 | 3.01% | ||
| 16 | GILEAD SCIENCES INC | 500,000 | 45,930,000 | 2.69% | Call | |
| 17 | BIOGEN INC | 175,000 | 45,556,000 | 2.67% | ||
| 18 | TENET HEALTHCARE CORP THC | 1,500,000 | 43,395,000 | 2.54% | ||
| 19 | QUEST DIAGNOSTICS INC | 600,000 | 42,870,000 | 2.51% | ||
| 20 | CARDIOVASCULAR SYSTEMS INC | 4,100,000 | 42,517,000 | 2.49% | ||
| 21 | UNIVERSAL AMERN CORP NEW | 5,875,000 | 41,948,000 | 2.46% | ||
| 22 | MASIMO CORP COM | 1,000,000 | 41,840,000 | 2.45% | ||
| 23 | Alkermes, Inc. | 1,200,000 | 41,028,000 | 2.40% | ||
| 24 | MEDIVATION INC | 825,000 | 37,934,000 | 2.22% | ||
| 25 | ARIAD PHARMACEUTICALS INC | 5,405,235 | 34,539,000 | 2.02% | ||
| 26 | ENDOLOGIX INC | 3,864,500 | 32,307,000 | 1.89% | ||
| 27 | INVITAE CORP | 2,746,622 | 28,098,000 | 1.65% | ||
| 28 | SEQUENOM INC | 17,325,000 | 24,428,000 | 1.43% | ||
| 29 | Wright Medical Group NV | 1,452,600 | 24,113,000 | 1.41% | ||
| 30 | ARENA PHARMACEUTICALS INC | 10,500,000 | 20,685,000 | 1.21% | ||
| 31 | ORASURE TECHNOLOGIES INC | 2,000,000 | 14,460,000 | 0.85% | ||
| 32 | AMAG PHARMACEUTICALS INC COM | 600,000 | 14,040,000 | 0.82% | ||
| 33 | BIOSCRIP INC | 6,180,000 | 13,225,000 | 0.77% | ||
| 34 | PROTALIX BIOTHERAPEUTICS INC | 13,275,000 | 11,158,000 | 0.65% | ||
| 35 | SYNERON MEDICAL LTD ORD SHS | 1,505,700 | 11,007,000 | 0.64% | ||
| 36 | INNOCOLL AG | 1,111,111 | 9,533,000 | 0.56% | ||
| 37 | DURECT CORP | 6,000,000 | 8,100,000 | 0.47% | ||
| 38 | BIOLASE INC | 5,332,394 | 6,985,000 | 0.41% | ||
| 39 | PROTALIX BIOTHERAPEUTICS INC | 9,000,000 | 6,000,000 | 0.35% | PRN | |
| 40 | PTC THERAPEUTICS INC | 893,900 | 5,757,000 | 0.34% | ||
| 41 | Catabasis Pharmaceuticals Inc | 1,000,000 | 5,040,000 | 0.30% | ||
| 42 | EPIRUS BIOPHARMA | 1,847,500 | 4,970,000 | 0.29% | ||
| 43 | GENMARK DIAGNOSTICS INC COM | 649,097 | 3,421,000 | 0.20% | ||
| 44 | ANGIODYNAMICS INC | 243,183 | 2,989,000 | 0.18% | ||
| 45 | CARDICA INC | 837,483 | 2,981,000 | 0.17% | ||
| 46 | UNILIFE CORP | 2,750,000 | 1,870,000 | 0.11% | ||
| 47 | TARGACEPT INC | 1,684,799 | 1,685,000 | 0.10% | PRN | |
| 48 | BIOLASE INC | 1,841,173 | 22,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001354488-16-007412, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
